Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:39 AM UTC
| NCT Number | NCT06897930 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 15 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 8, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06897930 is currently recruiting participants. This phase1 study for systemic lupus erythematosus is actively seeking new participants at 15 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06897930 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06897930 was last updated 1 week ago (July 8, 2026). HelloStudys verifies this status automatically.